SHINE: Trends and Satisfaction in Hypertensives using Aktiia Optical BP Monitoring Device


‍Recruitment for the Aktiia SHINE trial is currently on pause until February 2025. Please visit back in February and we will look forward to your application to the trial.

This study aims to observe how blood pressure changes over 12 weeks by collecting blood pressure readings from the Aktiia 24/7 device. The study will link the blood pressure readings with personal, lifestyle, and health information. The study will also assess participants’ feedback on their experience using the device.

The Aktiia device is a blood pressure monitoring device made up of a bracelet, cuff and study specific phone application (app).

Using a small, non-invasive at-home device is a possible way of reducing the number of people with high blood pressure and its associated complications worldwide.

User Manual Bracelet G1 27Jul2023
Patient Information Sheet 20Aug2024
Informed Consent Form 27Jul2024
User Manual Init I1 27Jul2023

Sponsored by

Patrocinado por

Gesponsert von

Gesponsert von

Opdrachtgever:

Aktiia

Participants

Participantes

Teilnehmenden

Deelnemers:

7500

People

Personen

Participate by

Participar mediante

Abschlussdatum

Uiterlijke Inschrijving:

June 30, 2025

30.6.2025

30.6.2025

30.6.2025

Study FAQs

Sign Up
Haga clic aquí para participar
Teilnehmen
Klik hier om deel te nemen

Who is the study for? 

  • Men or women aged 22-85
  • Individuals with high blood pressure, defined as a blood pressure reading within the last 12 months of either Systolic ≥145 and/or Diastolic ≥90 
  • Individuals with access to an iOS or Android smartphone

What is expected of me? 

  1. First, you will fill out a screening questionnaire on this website to see if you are eligible to take part.
  2. If you are eligible, you will be sent more information about the trial.  If you are still willing to participate you will be asked to actively signify your consent via an informed consent form.
  3. Once you have consented to take part you may be asked some further screening questions to ensure you are suitable for the study including providing evidence relating to your high blood pressure.
  4. You will be sent a trial device direct to your home address and you will be sent an email to prompt you to download the study specific smartphone application. An additional survey asking you some additional questions about your characteristics will be sent to you.
  5. Once the device is set-up you will complete a baseline questionnaire in the app.
  6. You will wear the device 24/7 for 12 weeks and perform weekly ‘syncs’ between the device bracelet, cuff and app.
  7. After 12 ‘syncs’ you will receive the week 12 questionnaire and your study participation is complete.

What is the benefit for me?

  • You will be able to keep the Aktiia device after the study. 
  • If you complete all study activities (3 questionnaires and 12 recalibrations) you will also receive a £50 voucher/payment for your participation in the study. The voucher can be used at a wide range of retailers which you will choose from.
  • Your participation may help to generate knowledge on how the device could be used in the future to improve management of high blood pressure.

Complete questionnaire to get started.

Sign Up
Haga clic aquí para participar
Teilnehmen
Klik hier om deel te nemen

SHINE: Trends and Satisfaction in Hypertensives using Aktiia Optical BP Monitoring Device


‍Recruitment for the Aktiia SHINE trial is currently on pause until February 2025. Please visit back in February and we will look forward to your application to the trial.

This study aims to observe how blood pressure changes over 12 weeks by collecting blood pressure readings from the Aktiia 24/7 device. The study will link the blood pressure readings with personal, lifestyle, and health information. The study will also assess participants’ feedback on their experience using the device.

The Aktiia device is a blood pressure monitoring device made up of a bracelet, cuff and study specific phone application (app).

Using a small, non-invasive at-home device is a possible way of reducing the number of people with high blood pressure and its associated complications worldwide.

User Manual Bracelet G1 27Jul2023
Patient Information Sheet 20Aug2024
Informed Consent Form 27Jul2024
User Manual Init I1 27Jul2023
Click here to take part
Haga clic aquí para participar
Teilnehmen
Klik hier om deel te nemen

Study for

Estudio dirigido a

Zielgrupper der Studie

Onderzoek voor:

Adults aged 22 to 85 years old, who have a recent high blood pressure reading living in the UK

Sponsored by

Patrocinado por

Gesponsert von

Opdrachtgever:

Aktiia

Participants

Participantes

Teilnehmenden

Deelnemers:

7500

People

Personen

Participate by

Participar mediante

Abschlussdatum

Duur van onderzoek:

June 30, 2025

30.6.2025

30.6.2025

30.6.2025

Who is the study for? 

¿A quién va dirigido el estudio?

Für wen ist die Studie geeignet?

Voor wie is het onderzoek bedoeld?

  • Men or women aged 22-85
  • Individuals with high blood pressure, defined as a blood pressure reading within the last 12 months of either Systolic ≥145 and/or Diastolic ≥90 
  • Individuals with access to an iOS or Android smartphone

What is expected of me? 

¿Qué se espera de mí?

Was wird von mir erwartet?

Wat wordt van mij verwacht?

  1. First, you will fill out a screening questionnaire on this website to see if you are eligible to take part.
  2. If you are eligible, you will be sent more information about the trial.  If you are still willing to participate you will be asked to actively signify your consent via an informed consent form.
  3. Once you have consented to take part you may be asked some further screening questions to ensure you are suitable for the study including providing evidence relating to your high blood pressure.
  4. You will be sent a trial device direct to your home address and you will be sent an email to prompt you to download the study specific smartphone application. An additional survey asking you some additional questions about your characteristics will be sent to you.
  5. Once the device is set-up you will complete a baseline questionnaire in the app.
  6. You will wear the device 24/7 for 12 weeks and perform weekly ‘syncs’ between the device bracelet, cuff and app.
  7. After 12 ‘syncs’ you will receive the week 12 questionnaire and your study participation is complete.
Contact our study team
shine@lindushealth.com

What is the benefit for me?

¿En qué me beneficia?

Welchen Nutzen habe ich davon?

Wat is het voordeel voor mij?

  • You will be able to keep the Aktiia device after the study. 
  • If you complete all study activities (3 questionnaires and 12 recalibrations) you will also receive a £50 voucher/payment for your participation in the study. The voucher can be used at a wide range of retailers which you will choose from.
  • Your participation may help to generate knowledge on how the device could be used in the future to improve management of high blood pressure.

Complete this questionnaire to take part.

Fülle diesen Fragebogen aus, um herauszufinden, ob Du berechtigt bist

Click here to take part
Teilnehmen
Get in touch
HomePlatformParticipantsCase StudiesNewsAboutCareersGlossaryContact Us